Del Fava Emanuele, Rimseliene Grazina, Flem Elmira, Freiesleben de Blasio Birgitte, Scalia Tomba Gianpaolo, Manfredi Piero
Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy, Bocconi University, Milan, Italy.
Department of Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
PLoS One. 2016 Sep 30;11(9):e0163636. doi: 10.1371/journal.pone.0163636. eCollection 2016.
This study applies mixture modelling to examine age-specific immunity to varicella zoster virus (VZV) infection in Norway based on the first large-scale serological study in the general population. We estimated the seropositive proportions at different ages and calculated the underlying force of infection by using a sample of 2103 residual sera obtained from patients seeking primary and hospital care. A rapid increase in the VZV-associated immunity is observed in the first years of life with 63% of children being immune by age 5. The increase in the immunity levels slows down thereafter, with a large proportion of adults still susceptible by age 20 (around 14.5%), thus at risk of serious sequelae of varicella infection. The corresponding force of infection peaks during the preschool period, subsequently declines to a minimum between ages 10 and 20 years, and afterwards moderately increases to reach a plateau lasting throughout the childbearing period. In comparison with the traditional cut-off approach, mixture modelling used the whole data without producing any inconclusive cases, led to an unbiased classification of individuals between susceptible and immune, and provided a smoother immune profile by age. These findings represent an important step towards any decision about the introduction of varicella vaccination in Norway, as they are a primary input for mathematical transmission models aimed at evaluating potential vaccination scenarios.
本研究基于普通人群的首次大规模血清学研究,应用混合模型来检测挪威不同年龄组对水痘带状疱疹病毒(VZV)感染的免疫力。我们利用从寻求初级和医院护理的患者中获取的2103份残留血清样本,估计了不同年龄的血清阳性比例,并计算了潜在感染率。在生命的最初几年中,观察到VZV相关免疫力迅速上升,到5岁时63%的儿童具有免疫力。此后,免疫力水平的上升放缓,很大一部分成年人到20岁时仍易感(约14.5%),因此有感染水痘严重后遗症的风险。相应的感染率在学龄前达到峰值,随后在10至20岁之间降至最低,之后适度上升并在整个生育期维持在一个平稳水平。与传统的截断方法相比,混合模型使用了全部数据,没有产生任何不确定的情况,能够对易感个体和免疫个体进行无偏分类,并按年龄提供了更平滑的免疫情况。这些发现是挪威就引入水痘疫苗做出任何决策的重要一步,因为它们是旨在评估潜在疫苗接种方案的数学传播模型的主要输入数据。